TRDA icon

Entrada Therapeutics
TRDA

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$20
71% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
67% 1-yr TRDA win rate
18 Feb ‘26 12 days ago
Guggenheim
Guggenheim
Debjit Chattopadhyay
100% 1-yr TRDA win rate
11 Feb ‘26 19 days ago